IL17A and melanoma: The expression of LL-37 on myeloid cells in dermis is correlated with levels of proinflammatory cytokines such as IL-23p19, IL-17A, and TNF-α [6,7], which could promote tumor progression via angiogenesis in melanoma and non-melanoma skin cancers [8,9,10,11].